{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:49:37Z","timestamp":1791179377421,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journalofsurgicalresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.jss.2014.03.076","type":"journal-article","created":{"date-parts":[[2014,4,2]],"date-time":"2014-04-02T05:06:27Z","timestamp":1396415187000},"page":"718-723","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Clinical significance of microRNA 138 and cyclin D3 in hepatocellular carcinoma"],"prefix":"10.1016","volume":"193","author":[{"given":"Bo","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoyuan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2014.03.076_bib1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jss.2014.03.076_bib2","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1200\/JCO.2009.25.9895","article-title":"Advanced hepatocellular carcinoma: which staging systems best predict prognosis?","volume":"28","author":"Huitzil-Melendez","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2014.03.076_bib3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1089-3261(05)70158-6","article-title":"The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma","volume":"5","author":"Johnson","year":"2001","journal-title":"Clin Liver Dis"},{"issue":"Suppl 1","key":"10.1016\/j.jss.2014.03.076_bib4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1478-3231.2010.02395.x","article-title":"Novel molecular therapies in hepatocellular carcinoma","volume":"31","author":"Faivre","year":"2011","journal-title":"Liver Int"},{"key":"10.1016\/j.jss.2014.03.076_bib5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrc1840","article-title":"Oncomirs: microRNAs with a role in cancer","volume":"6","author":"Esquela-Kerscher","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jss.2014.03.076_bib6","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrc1997","article-title":"MicroRNA signatures in human cancers","volume":"6","author":"Calin","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jss.2014.03.076_bib7","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S1673-8527(07)60109-X","article-title":"Identification of differentially expressed microRNAs during the development of Chinese murine mammary gland","volume":"34","author":"Wang","year":"2007","journal-title":"J Genet Genomics"},{"key":"10.1016\/j.jss.2014.03.076_bib8","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03702","article-title":"MicroRNA expression profiles classify human cancers","volume":"435","author":"Lu","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jss.2014.03.076_bib9","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/ijc.25014","article-title":"miRNA control of tumor cell invasion and metastasis","volume":"126","author":"Baranwal","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jss.2014.03.076_bib10","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.yexcr.2013.02.025","article-title":"miR-138 overexpression is more powerful than hTERT knockdown to potentiate apigenin for apoptosis in neuroblastoma in\u00a0vitro and in\u00a0vivo","volume":"319","author":"Chakrabarti","year":"2013","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.jss.2014.03.076_bib11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/1479-5876-11-275","article-title":"Down-regulation of miR-138 promotes colorectal cancer metastasis via directly targeting TWIST2","volume":"11","author":"Long","year":"2013","journal-title":"J Transl Med"},{"key":"10.1016\/j.jss.2014.03.076_bib12","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/ijc.25320","article-title":"Downregulation of the Rho GTPase signaling pathway is involved in the microRNA-138-mediated inhibition of cell migration and invasion in tongue squamous cell carcinoma","volume":"127","author":"Jiang","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jss.2014.03.076_bib13","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000343349","article-title":"MiR-138 inhibits tumor growth through repression of EZH2 in non-small cell lung cancer","volume":"31","author":"Zhang","year":"2013","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.jss.2014.03.076_bib14","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/carcin\/bgs113","article-title":"MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma","volume":"33","author":"Wang","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jss.2014.03.076_bib15","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0092-8674(94)90543-6","article-title":"Cyclins and cancer II: cyclin D and CDK inhibitors come of age","volume":"79","author":"Hunter","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.jss.2014.03.076_bib16","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/ijc.28086","article-title":"MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF-1\u03b1","volume":"133","author":"Yeh","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jss.2014.03.076_bib17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/1947601913484495","article-title":"MicroRNA profile to predict gemcitabine resistance in bladder carcinoma cell lines","volume":"4","author":"Kozinn","year":"2013","journal-title":"Genes Cancer"},{"key":"10.1016\/j.jss.2014.03.076_bib18","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1530\/ERC-13-0357","article-title":"A miRNA signature associated with human metastatic medullary thyroid carcinoma","volume":"20","author":"Santarpia","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.jss.2014.03.076_bib19","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.bbadis.2013.05.015","article-title":"Suppression of tumorigenicity by microRNA-138 through inhibition of EZH2-CDK4\/6-pRb-E2F1 signal loop in glioblastoma multiforme","volume":"1832","author":"Qiu","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jss.2014.03.076_bib20","doi-asserted-by":"crossref","first-page":"350","DOI":"10.7150\/jca.6394","article-title":"Comprehensive microRNA profiling of prostate cancer","volume":"4","author":"Walter","year":"2013","journal-title":"J Cancer"},{"key":"10.1016\/j.jss.2014.03.076_bib21","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.celrep.2012.07.012","article-title":"Targeting glioma stem cells by functional inhibition of a prosurvival oncomiR-138 in malignant gliomas","volume":"2","author":"Chan","year":"2012","journal-title":"Cell Rep"},{"key":"10.1016\/j.jss.2014.03.076_bib22","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0092-8674(94)90540-1","article-title":"G1 phase progression: cycling on cue","volume":"79","author":"Sherr","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.jss.2014.03.076_bib23","first-page":"559","article-title":"Fluorescence in situ hybridization analysis of CCND3 gene as marker of progression in bladder carcinoma","volume":"27","author":"Beltran","year":"2013","journal-title":"J Biol Regul Homeost Agents"},{"key":"10.1016\/j.jss.2014.03.076_bib24","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ccr.2012.09.015","article-title":"The requirement for cyclin D function in tumor maintenance","volume":"22","author":"Choi","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jss.2014.03.076_bib25","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.lungcan.2011.04.004","article-title":"High cyclin D3 expression confers erlotinib resistance in aerodigestive tract cancer","volume":"74","author":"Petty","year":"2011","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jss.2014.03.076_bib26","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10549-010-0821-3","article-title":"Nicotine-induced human breast cancer cell proliferation attenuated by garcinol through down-regulation of the nicotinic receptor and cyclin D3 proteins","volume":"125","author":"Chen","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jss.2014.03.076_bib27","doi-asserted-by":"crossref","first-page":"820","DOI":"10.4161\/cc.9.4.10783","article-title":"Cyclin D3 is dispensable for human diffuse large B-cell lymphoma survival and growth:\u00a0evidence for redundancy with cyclin E","volume":"9","author":"Gumina","year":"2010","journal-title":"Cell Cycle"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480414003539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480414003539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T15:14:42Z","timestamp":1716650082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480414003539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0022480414003539"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2014.03.076","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical significance of microRNA 138 and cyclin D3 in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Surgical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jss.2014.03.076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}